Bufomix Easyhaler® (budesonide/formoterol)
Support Items
Patient support |
10/08/2020
Prescribing information available here and Adverse Event Reporting information can be found at the bottom of the page
At Orion Pharma we understand how important it is for you to be able to support and train your patients on the correct use of their inhaler device.
If you would like to receive Bufomix Easyhaler® support items or be contacted by an Orion Pharma representative then please fill out the form below.
If you have a medical enquiry, or wish to report an adverse event, then please contact our medical team directly - ie.medicalinformation@orionpharma.com.
By clicking here I accept that my personal data will be collected and processed by Orion Pharma and that my data will only be used for this particular request.
If you would like more information on how Orion Pharma processes your data please see our privacy policy here:
https://www.orionpharma.ie/policies/orion-corporation-general-privacy-statement/
+There is no obligation to see a representative to receive any items *Required information to process this request
Date of preparation: March 2024 / EASYH-882(2)
| Adverse effects should be reported. You can report side effects directly via the Health Products Regulatory Authority (HPRA) website: www.hpra.ie or by email on medsafety@hpra.ie. Adverse effects should also be reported to Orion Pharma via ie.medicalinformation@orionpharma.com |
Was this article useful?
DATE OF PREPARATION: MAY 2023/EASYH-688(10)
FULL PRESCRIBING INFORMATION AVAILABLE HERE
For more information about Orion and Sustainability click here
| Adverse effects should be reported. You can report side effects directly via the Health Products Regulatory Authority (HPRA) website: www.hpra.ie or by email on medsafety@hpra.ie. Adverse effects should also be reported to Orion Pharma via ie.medicalinformation@orionpharma.com |
